IDEXX LABORATORIES INC /DE
IDEXX LABORATORIES INC /DE
WESTBROOK, ME
Loading...
Price History
Market Data
| Market Cap | -101.37M |
| P/E Ratio | - |
| P/B Ratio | -0.06 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 1.09 |
| Current Ratio | 1.23 |
| Currency | USD |
Key Financial Metrics
4.30B
Revenue
1.06B
Net Income
-
EPS (Diluted)
1.62B
Free Cash Flow
Profitability
Gross Margin
61.8%
Operating Margin
31.6%
Net Profit Margin
24.6%
EBITDA
1.61B
Returns & Efficiency
Return on Assets (ROA)
31.6%
Return on Equity (ROE)
66.0%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
3.35B
Total Debt
450.00M
Debt to Equity
1.09x
Current Ratio
1.23
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | WESTBROOK, ME |
| Fiscal Year | 2025 |
Peers
9.05B
P/E: --
VENAXIS, INC.
RIOT
9.05B
P/E: --
BIOPTIX, INC.
RIOT
9.05B
P/E: --
9.05B
P/E: --
5.94B
P/E: 28.0
ARCA BIOPHARMA, INC.
ORKA
3.76B
P/E: --
3.76B
P/E: --
2.61B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$-101.37M
P/E Ratio (TTM)-
Price to Book-0.06
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin61.8%
Operating Margin31.6%
Net Margin24.6%
ROE66.0%
ROA31.6%
Leverage & Liquidity
Debt to Equity1.09
Current Ratio1.23
Total Debt$450.00M
Total Assets$3.35B
Stockholders' Equity$1.61B
Income Statement (FY 2025)
Revenue$4.30B
Gross Profit$2.66B
Operating Income$1.36B
Net Income$1.06B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$1.62B
Cash & Equivalents$180.07M
Revenue Growth10.4%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | ONE IDEXX DRIVE WESTBROOK, ME 04092-2041 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 010393723 |
| Fiscal Year End | 1231 |
| Shares Outstanding | -178,000.00 |
| Stockholders' Equity | $1.61B |
| Cash & Equivalents | $180.07M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-05
Local
4/A
Amended Insider Transaction
Amendment to statement of changes in ownership
Filed: 2026-03-03
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-26
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-25
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-20
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | IDEXX LABORATORIES INC /DE |
| Ticker | IDXX |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | WESTBROOK, ME |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | -101.37M |
| Revenue | 4.30B |
| Net Income | 1.06B |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 24.6% |
| ROE | 66.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...